Shanghai Pharmaceuticals Holding Co. Ltd. (2607)
Market Closed
11 Aug, 08:00
11. 79
HKD -0.11
-0.9244%
- Market Cap
- P/E Ratio
0.06% Div Yield
1.32M Volume
0 Eps
11.9 HKD
Previous Close Want to track 2607 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
2607 closed today lower at 11.79 HKD, a decrease of -0.9244% from yesterday's close, completing a monthly increase of 2.8796% or 0.33 HKD. Over the past 12 months, 2607 stock gained 3.6939%.
2607 pays dividends to its shareholders, with the most recent payment made on Feb 06, 2026. The next announced payment will be in In 1 weeks on Aug 24, 2026 for a total of 0.405 HKD.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0604%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on HKEX (HKD).
2607 Chart
Shanghai Pharmaceuticals Holding Co. Ltd. (2607) FAQ
What is the stock price today?
The current price is 11.79 HKD.
On which exchange is it traded?
Shanghai Pharmaceuticals Holding Co. Ltd. is listed on HKEX.
What is its stock symbol?
The ticker symbol is 2607.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.06%.
What is its market cap?
As of today, no market cap data is available.
Has Shanghai Pharmaceuticals Holding Co. Ltd. ever had a stock split?
No, there has never been a stock split.
Shanghai Pharmaceuticals Holding Co. Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | HKEX Exchange | CNE1000012B3 ISIN |
| China Country | 49,402 Employees | 14 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Shanghai Pharmaceuticals Holding Co. Ltd. is a comprehensive pharmaceutical company engaged in both the production and distribution of pharmaceuticals in China. It operates through multiple divisions primarily focusing on pharmaceutical manufacturing, distribution, and retail. The company's primary function is to develop a wide array of pharmaceuticals, including chemical drugs, traditional Chinese medicines, and medical devices. Its products cater to various healthcare needs and are critical to the medical industry across the region. Notably, the company extends its reach beyond local markets, actively engaging in international collaborations to innovate and expand its product line. Shanghai Pharmaceuticals plays a significant role in the healthcare sector by ensuring the availability and accessibility of essential medicines, supporting China's expansive healthcare infrastructure. The company is also a pivotal part of China's efforts to enhance its pharmaceutical industry, contributing to the sector's growth and development in line with global standards. As one of the leading pharmaceutical firms in Asia, Shanghai Pharmaceuticals Holding Co. Ltd. continues to influence healthcare trends and practices.
Contact Information
Address: Shanghai Pharmaceutical Building
Phone: 86 21 6373 0908
Website: https://www.sphchina.com
